Original article
Therapeutic benefit in patients switching tolterodine to other novel antimuscarinic agents
Beneficio terapéutico tras cambiar tolterodina por otros nuevos antimuscarínicos
a Departamento de Urología, Hospital General Universitario de Valencia, Valencia, Spain
b Departamento de Ginecología, Hospital de Fuenlabrada, Madrid, Spain
c Unidad Médica, Pfizer, S.L.U., Alcobendas, Madrid, Spain
d Departamento de Investigación de Resultados en Salud y Farmacoeconomía, Pfizer, S.L.U., Alcobendas, Madrid, Spain
e Departamento Médico, Pfizer Europe, Alcobendas, Madrid, Spain
Read
794
Timeswas read the article
221
Total PDF
573
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 3 | 2 | 2 | 4 |
| 2018 2 | 7 | 4 | 11 |
| 2018 1 | 9 | 3 | 12 |
| 2017 12 | 25 | 0 | 25 |
| 2017 11 | 42 | 2 | 44 |
| 2017 10 | 35 | 6 | 41 |
| 2017 9 | 36 | 8 | 44 |
| 2017 8 | 54 | 1 | 55 |
| 2017 7 | 31 | 5 | 36 |
| 2017 6 | 37 | 4 | 41 |
| 2017 5 | 29 | 2 | 31 |
| 2017 4 | 21 | 6 | 27 |
| 2017 3 | 37 | 27 | 64 |
| 2017 2 | 35 | 0 | 35 |
| 2017 1 | 19 | 2 | 21 |
| 2016 12 | 30 | 6 | 36 |
| 2016 11 | 33 | 6 | 39 |
| 2016 10 | 33 | 5 | 38 |
| 2016 9 | 7 | 6 | 13 |
| 2016 8 | 10 | 4 | 14 |
| 2016 7 | 10 | 3 | 13 |
| 2016 6 | 5 | 23 | 28 |
| 2016 5 | 16 | 10 | 26 |
| 2016 4 | 9 | 21 | 30 |
| 2016 3 | 0 | 11 | 11 |
| 2016 2 | 0 | 11 | 11 |
| 2016 1 | 0 | 12 | 12 |
| 2015 12 | 0 | 9 | 9 |
| 2015 11 | 0 | 1 | 1 |
| 2015 10 | 0 | 11 | 11 |
| 2015 9 | 1 | 6 | 7 |
| 2015 8 | 0 | 1 | 1 |
| 2015 7 | 0 | 1 | 1 |
| 2015 3 | 0 | 1 | 1 |
| 2014 7 | 0 | 1 | 1 |
Show all
